Evaluation of prophylactic effect of Livergol (Silymarin) on liver function tests in patients with outpatient cancer undergoing chemotherapy

Phase 3

Recruiting

• Conditions: Chemotherapy induced liver injury.; Injury of liver; S36.11

• Registration Number: IRCT20201123049474N2
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 105

Inclusion Criteria

Patients aged 30 to 60 years
Ability to take the drug orally
Definitive diagnosis of breast cancer that has chemotherapy indications and has not yet received its chemotherapy drug
Liver tests are normal before the intervention
Indication of treatment with chemotherapy regimen

Exclusion Criteria

pregnant and breastfeeding
liver metastasis and liver disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
iver function test. Timepoint: Measurement of liver enzymes at the beginning of the study (before the intervention) and 3 and 6 weeks after the start of silymarin. Method of measurement: Lab data.